Nodal Staging in Breast Cancer With MRL

NCT01609920 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

97

Enrollment

OTHER

Sponsor class

Stopped Manufacturer recently halted production of gadofosveset.

Conditions

Breast Neoplasms

Interventions

DRUG: Gadofosveset enhanced MRL of axillary lymph nodes

Sponsor

Maastricht University Medical Center